Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lower Limb Fracture
1 trial -
Dexmedetomidine
Hospital Authority, Hong Kong
Thyroid Diseases
1 trial -
Dexmedetomidine
Peking University Third Hospital
Aged
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Renal Function
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Postoperative Delirium After Living Donor Renal Transplantation
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Post-Surgical Pain
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thoracic Paravertebral Blocks
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Overall Survival
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Older Patients
1 trial -
Dexmedetomidine
Peking University Third Hospital
Breast Cancer
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Elderly
3 trials -
Dexmedetomidine Group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Dexmedetomidine Injectable Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epilepsy
1 trial -
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Dextrose 5%
Hospital Authority, Hong Kong
End-Stage Kidney Disease
1 trial -
Diane-35 pretreatment
The First People's Hospital of Lianyungang
Polycystic Ovary Syndrome
1 trial -
Digaoxin,amiodarone,Ξ² receptor antagonist, Calcium Antagonists
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Atrial Fibrillation
1 trial -
Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Multiple Myeloma
1 trial -
EUS-guided pancreatic pseudocyst drainage
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pancreatic Pseudocyst
1 trial -
EV71 Vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hand, Foot and Mouth Disease
1 trial -
Echocardiographic guidance
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aortic Stenosis
1 trial -
Edaravone Dexborneol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chemo Brain
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources